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Abstract 
Purpose: It is unclear whether Maltese 
cancer patients wish to know their diagnosis 
or to what extent they want to be informed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The aim was to assess patients’ 
preferences for receiving a cancer diagnosis 
and being involved in the decision-making 
process, and then compare these with results 
from similar international studies.  
Methods: Two hundred fifty-two 
Maltese adult cancer patients were invited to 
complete two standardised tools: the 
Measure of Patients’ Perspective (MPP), 
assessing patients’ preferences for receiving 
news about their cancer, and the Control 
Preferences Scale (CPS), examining 
involvement in decision-making.  
Results: Maltese patients rated the 
‘content’ subscale (information given; mean 
4.17, SD 0.59) as significantly more 
important (p<0.001) than ‘support’ (offering 
comfort/support; mean 3.73, SD 0.68) and 
‘facilitation’ (how information is given; 
mean 3.86, SD 0.68). Patients with higher 
levels of education had significantly higher 
scores for ‘content’ (p=0.018) and 
‘facilitation’ (p<0.001) on the MPP, while 
lower education levels preferred a passive 
role (p=0.01) on the CPS. Although there is 
a trend towards a collaborative and even an 
active role in treatment decisions, patients 
still exhibit a paternalistic attitude towards 
their physician. Age, gender and medical 
variables had no significant influence on 
response. 
Conclusions: Maltese cancer patients 
want to be informed of their cancer 
diagnosis, its treatment and prognosis, 
similar to other international studies. 
However, 60% of Maltese patients prefer a 
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more paternalistic approach towards their 
physician when compared to other studies. 
Keywords 
patient preference, patient rights, health 
literacy, decision making, neoplasms 
Introduction 
Cancer is a significant disease in Malta, 
with 1200 Maltese residents presenting with 
new cancers each year (Malta National 
Cancer Registry 2002). A diagnosis of 
cancer goes hand in hand with breaking bad 
news, which is usually delivered by hospital 
doctors as the majority of investigations are 
hospital-based. To break bad news 
effectively, physicians must devote time to 
the patient, giving information accordingly, 
answering any questions that may arise, and 
dealing with the aftermath of such 
disclosure. Truth-telling is becoming 
increasingly advocated and offers far-
reaching benefits to all involved.1 
Background 
From a medical point of view, bad 
news has been defined as:  
 “any information which 
adversely and seriously affects 
an individual's view of his or 
her future”.2 
This can be viewed on two levels: a 
level at which life is temporarily interrupted, 
such as replacing a hip joint, and a deeper 
level which threatens the continuity of life, 
as is the case with malignant disease.3 
Unfortunately, the field of oncology is 
riddled with bad news, ranging from 
disclosure of a diagnosis, through treatment 
failure, to recurrence of disease and end of 
life issues. The way bad news is broken can 
have a profound effect on improving 
patients’ compliance with treatment, may 
lead to a clearer understanding of 
instructions or symptoms, may help reduce 
stress and anxiety, and improve overall 
patient satisfaction.4-5 On the other hand, 
delivered inappropriately or insensitively, 
bad news may exert a lasting impact on the 
ability to adapt and adjust, whilst also 
inviting the risk of litigation.6 Inappropriate 
delivery of unfavourable news includes 
usage of unfamiliar medical jargon or giving 
scanty information. Recipients of such 
messages may feel confused, anxious or 
angry.3  
In recent decades there has been a 
dramatic shift towards disclosure of cancer 
diagnosis in Western Countries, especially 
in North America, Australia and most of 
Europe.5 The previous paternalistic attitude 
favouring concealment in order to protect 
the patient has become overshadowed by the 
growing importance of safeguarding patient 
autonomy.7 Patients are considered to have a 
moral and legal right to receive accurate and 
reliable information, and it remains the 
doctor’s responsibility to deliver the 
diagnosis accurately and explain treatment 
options clearly.3 The content of discussions 
needs to be honest so that patients can 
provide informed consent about their 
treatment.6 This has undoubtedly been a step 
in the right direction – patients are now 
better informed and more respected.7  
There is no data regarding the standard 
practice about truth telling to patients in 
Malta. Only recently, a Patient Charter 
document was brought into effect locally. 
Principle 4 of the Charter deals with Shared 
Decision-Making and Informed Consent, 
specifying that “one has the right to 
participate in the collaborative process of 
decision-making related to one’s particular 
health-care needs and to make an informed 
consent about one’s treatment and care”.8 
Our research therefore fits in with the 
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climate in which changes are being made 
locally in the field of shared decision-
making. 
 
Patients and methods 
Participants and Procedures 
The intention of this cross-sectional 
survey was to investigate preferences for 
truth-telling about cancer and involvement 
in treatment decisions among Maltese 
cancer patients aged eighteen and over. With 
a total Maltese population of a little over 
400,000 people, Malta has one oncology 
centre, and the out-patient follow-up clinics 
were therefore considered an ideal location 
for recruiting patients for the study.  
 A consecutive sample of oncology 
patients were approached in the waiting area 
by the researcher who was not a member of 
the oncology team, and were invited to 
voluntarily complete an anonymous 
questionnaire in Maltese which would take 
around twelve minutes. The self-completed 
questionnaire was presented as a seven-page 
booklet consisting of an information sheet 
for patients, demographic and medical data 
to be filled by the patients and caring 
physician, and the questionnaires 
themselves. Field work was carried out 
every day for two consecutive weeks. The 
researcher was available at all times to 
answer any queries and respondents were 
also furnished with a leaflet about the nature 
of the study, and contact details of the 
researcher.  Data was collected by 
quantitative methods. 
Inclusion criteria were: diagnosis of 
any type of solid tumour cancer at least a 
month prior to interview, having received at 
least one type of treatment (chemotherapy, 
radiotherapy, hormonal or other therapy), 
awareness of a cancer diagnosis and Maltese 
literacy.  Exclusion criteria were: aged 
younger than eighteen, non-natives, non-
cancer diagnosis, and diagnosis less than 
one month prior to fieldwork. Prior to 
commencement of research, permission was 
sought from the Data Protection Board and 
University Research Ethics Committee 
(UREC) of the University of Malta. 
Two hundred sixty-nine patients were 
approached to participate in the study, of 
which seventeen met the exclusion criteria. 
All the returned questionnaires were valid, 
in that most responses had been filled in and 
could therefore be used for analysis. The 
questionnaire delivered to patients was 
bipartite, consisting of the Measure of 
Patient Preferences (MPP) Questionnaire 
and the Control Preferences Scale (CPS). 
The thirty-two-item MPP, scored on a five-
point scale (1-5) and initially developed in 
the United States by Parker et al., was used 
to assess preferences for characteristics of 
the bad news encounter. Preferences relate 
to three aspects: ‘facilitation’ - the setting in 
which the news is delivered; the ‘content’ of 
the message; and the ‘support’ offered.4 To 
understand to what degree patients are being 
involved in the decision-making process, the 
two-item Control Preferences Scale (CPS), 
developed in Canada by Degner et al. was 
used.9 This five-point (A-E) self-reported 
scale assesses patients’ preferences for 
control in medical decision-making, ranging 
from a wholly active role (A) through to a 
wholly passive role (E). The tool allows 
respondents to portray how they were 
involved in treatment decisions (CPS-1), 
and then to express how they would have 
liked to have been involved (CPS-2).  
 
Outcome Measures 
Permission was obtained from the 
authors of the MPP and CPS to utilise their 
questionnaire, who are also authors of this 
research. The questionnaires were translated 
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from English into Maltese by a senior 
lecturer of the Maltese language, followed 
by conceptual translation to ascertain that 
concepts were understood in the same way, 
and to ensure cultural acceptability of the 
questionnaire. The corrected questionnaire 
then underwent cognitive debriefing 
whereby it was actively tested among 
representatives of the target population to 
assess whether the questionnaire was being 
understood in the same way as the original 
would have. Following the amendments 
made, the product tool was considered to be 
reliable for usage in the Maltese sample 
population. Validity testing was not 
necessary since this had already been done 
by Parker et al., and Degner et al. in their 
respective studies which produced the MPP 
and CPS.  The questionnaire was then 
pilotted prior to actual usage. 
 
Demographics and Medical Data 
Demographic information, including 
gender, age, marital status and educational 
level was collected. Participants supplied 
information on stage of disease and 
recurrence status, while their physicians 
gave additional information on cancer type, 
date of diagnosis, stage of disease and 
recurrence, and treatment given (Table 1). 
Statistical Analysis 
Descriptive statistics were presented for 
demographic and medical characteristics of 
the sample, while univariate analysis was 
conducted to examine independent 
associations between respondents’ 
demographic and clinical characteristics, 
and the MPP and CPS data.  Since the MPP 
is assessed through scores, tests for 
differences between means were used.  T-
Tests and one-way ANOVA were used as 
applicable. For the CPS categorical data, 
odds ratios (OR) were used to assess 
independent associations between the 
demographic variables and CPS category. 
These associations were then assessed using 
multinomial regression analysis while 
adjusting for any possible confounding 
factors.  
For all tests, a p<0.05 was used to 
assess statistical significance, and 
confidence intervals (CI) of 95% were 
presented as applicable.  
 
Results 
Two hundred fifty-two patients were 
eligible to participate in the study, of which 
forty-two were physically, cognitively or 
psychologically unable to complete the 
questionnaire, and 11 refused to participate. 
Thus, the participation rate was 79%, similar 
to that obtained in other studies which 
registered similar eligibility criteria.16 
Patients who refused to participate did not 
differ by age (p=0.758) or gender (p=0.993) 
when compared to respondents.  
The mean time from diagnosis to 
completion of the questionnaire was 52.3 
months (4.4 years), somewhat more than 
that in Parker et al.’s study (3.3 years),4 the 
long duration resulting from the prolonged 
follow-up necessary before a patient can be 
declared disease-free. There was no 
statistical significance between those with a 
recent or distant diagnosis. Some had 
received bad news twice, once on diagnosis 
and again on recurrence.  
Females accounted for 67.3%, and the 
age range of participants was 27 to 86 years 
(mean 62.2 years; SD 12.6 years), similar to 
that observed in the Canadian population study 
(mean 62.4 years, SD 8.4, range 46-85),14 and 
the Japanese population study (62 years, SD 11, 
range 26-97).16 Of note, less than a fifth had 
completed tertiary education, which was similar 
to a British study where 20.0% had attended 
college or received a graduate degree.13  
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Table 1: Demographic and medical characteristics of the population sampled
Characteristics % (n) 
Mean time from diagnosis 4.4 years (SD 4.48) 
Gender (n=199) 
Male 32.7 (65) 
Female 67.3 (134) 
Mean Age (n=199) 62.2 years (SD 12.6 years) 
Marital Status (n=199) 
Married/Living with Partner 68.3 (136) 
Widowed 12.6 (25) 
Single 12.6 (25) 
Separated/Divorced 6.5 (13) 
Level of education reached (n=197) 
Primary 41.6 (82) 
Secondary or Post-Secondary 41.1 (81) 
Tertiary or Post-Graduate 17.2 (34) 
Employment Status (n=198) 
Domestic Tasks 40.9 (81) 
Retired 31.3 (62) 
Employed 24.3 (48) 
Unemployed 3.5 (7) 
Cancer Type (n=196) 
Breast 37.8 (74) 
Gastrointestinal Tract 13.8 (27) 
Prostate 9.2 (18) 
Gynaecologic 7.1 (14) 
Urological 7.1 (14) 
Haematological 6.6 (13) 
Lung 5.6 (11) 
Thyroid 5.6 (11) 
Other cancers 7.1 (14) 
Cancer Recurrence (n=196) 
Yes 21.9 (43) 
No 78.1 (153) 
Mean time 2.49 years (SD 2.68) 
Several types of cancers were 
represented in the population sampled, 
including rare cancers, reflecting the 
distribution of cancer types in the Maltese 
Islands, being similar to those found in the 
Italian population study15 (Table 1). The 
large majority of respondents (91%) 
accurately reported their diagnosis, and 
36.7% were able to stage their disease. More 
males (72.3%) tended not to know their 
stage compared to females (60.4%), but this 
was not significant (p=0.101). Younger 
patients were more likely to know their 
disease stage than older ones (p=0.017). Of 
the 71 patients who documented a stage, 16 
had no physician-listed stage to compare to. 
60% of the remaining reported the correct 
stage, while 59% of incorrect answers 
quoted a less advanced stage of disease. 
Most of the patients received at least two 
types of treatments/interventions, with 
surgery being the most common (Table 2). 
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Table 2: Percentage distribution of surgical 
and anti-cancer treatments which patients 
received (patients could have had more than 
one treatment/intervention) 
Surgical and anti-
cancer treatments % (n) 
Surgery 70.9 (141) 
Radiotherapy 57.1 (114) 
Hormonal Therapy 44.9 (89) 
Chemotherapy 41.3 (82) 
Palliative 2.6 (5) 
Other 9.2 (18) 
 
‘Recurrence’ in this study refers to the 
re-appearance of a previously quiescent 
disease, or advancement of disease which 
was previously stable. Just over a fifth 
(21.9%) had had a recurrence by the time of 
the survey, which is less than those observed 
in an American (31%)4 and British 
population (52.7%)13.  The mean number of 
months from diagnosis to recurrence was 
29.9 months (SD 32.2 months).  
 
MPP  
The highest scoring item was ranked at 
4.35 (SD 0.81), which comes close to results 
from the American (4.72, SD 0.49)4 and 
British (4.62, SD 0.67)13 studies. Table 3 
represents the ten highest and lowest scoring 
items on the MPP, with seven out of the 
highest and six out of the lowest scorings 
being common between the Maltese, 
American4, and British13 studies. The lowest 
scores in this study nonetheless ranked 
greater than 3.0, indicating that all items in 
the questionnaire were considered important 
by respondents.   
The same three categories as those 
identified by Parker et al.4 were used in this 
study: ‘Content’, ‘Support’ and 
‘Facilitation’. The mean score for ‘Content’ 
was 4.17 (SD 0.59), for ‘Support’ 3.73 (SD 
0.68) and for ‘Facilitation’ 3.86 (SD 0.68).  
These results were mirrored by those 
obtained in American4, British13, and 
Canadian14 studies. The mean score for 
‘Content’ was significantly higher compared 
to ‘Support’ (p<0.001) and ‘Facilitation’ 
(p<0.001). 
When considering demographic and 
medical characteristics of the population vis-
a-vis the MPP category scores, education 
proved to be the only significant predictor, 
significantly associated with the ‘Content’ 
(p=0.018) and ‘Facilitation’ (p<0.001) sub-
scales.  Those with primary education 
reported a lower average ‘Content’ score 
than those with tertiary education (p=0.021), 
and likewise for ‘Facilitation’ in both the 
primary (p<0.001) and secondary education 
(p=0.002) sub-groups, hence suggesting that 
those with tertiary education place more 
importance on the ‘Content’ of the 
physician-patient dialogue and on how and 
where bad news is broken (‘Facilitation’). 
These results are in-keeping with those 
obtained from the American study, where 
education significantly predicted scores on 
the ‘content’ and ‘facilitation’ subscales.4 
 
CPS 
Two-thirds of respondents (68.2%) 
experienced a passive role, with a quarter 
(25.9%) having a collaborative role, and 
only 5.8% an active role (CPS 1). In CPS-2, 
although the passive role remains the most 
popular, this drops from 68.3% to 59.7% 
indicating a shift to the collaborative and 
active role (Figure 1). None of the patients’ 
demographic or medical characteristics 
increased the likelihood of having either role 
compared to a passive role (reference group) 
in CPS-1. 
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Table 3: Highest and lowest MPP ratings 
Highest ratings MPP Mean (SD) 
My doctor describing all of my treatment options in detail 4.35 (0.81) 
My doctor telling me the best treatment option 4.35 (0.75) 
My doctor being up to date on research on my type of cancer 4.34 (0.69) 
Having my doctor take the time to answer all of my questions completely 4.32 (0.77) 
Having my doctor give me his/her full attention 4.25 (0.83) 
Being given enough time to ask all of my questions about my cancer and 
the available treatments 
4.24 (0.74) 
My doctor letting me know all of the different treatment options 4.21 (0.77) 
Having the doctor be honest with me about the severity of my condition 4.19 (0.92) 
Waiting until all test results are in and he/she is certain about the news 
before telling me 
4.17 (0.85) 
Being given detailed information about the results of medical tests 4.14 (0.80) 
Lowest ratings MPP  
My doctor telling me about support services that are available to me 3.82 (0.88) 
Being told in person rather than over the phone 3.71 (1.11) 
Being told in a private, quiet setting 3.69 (1.07) 
Telling me it’s ok if I become upset 3.66 (0.95) 
Having the doctor tell me about resources in the community 3.57 (0.96) 
Having the doctor inform my family members about my prognosis 3.52 (1.14) 
Having another health care provider present to offer support and 
information 
3.51 (1.08) 
Having the doctor inform my family members about my diagnosis 3.49 (1.17) 
Having my doctor maintain eye contact during the meeting 3.39 (1.12) 
My doctor helps me to figure out how to tell my family and friends about 
the cancer 
3.38 (1.17) 
 
However, in CPS 2, there was a 
significant difference between primary and 
tertiary education (p=0.028); those in 
primary education were 81% times less 
likely (95% CI 0.04 – 0.84) to desire an 
active role than a passive role compared to 
the tertiary education group.  These results 
mirror the preferences of British patients,13 
yet contrast with Canadian patients, where 
education had no significant effect on the  
 
 
preferred role.14 This demonstrates a desire 
for an increasingly active role with 
increasing levels of education. None of the 
other univariate analyses of independent 
associations were significant.  
Since age and gender probably 
influence education level, a multivariate 
analysis adjusting for these two variables 
was conducted, revealing a more significant 
p-value (p=0.01), an OR of 0.12 and a 
narrower CI (0.26-0.60) (Table 4). 
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Figure 1: Distribution of responses for each of the items CPS 1 (n=187) and CPS 2 
(n=191).  Error bars indicate 95% confidence intervals around the proportions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4:  Final multivariate model for predicators and CPS2 as outcome.  Passive is the 
reference group 
 
Active Collaborative 
 
OR (95% CI) p-value OR (95% CI) p-value 
 
  
    
Gender          
Male 0.78 (0.23 - 2.60) 0.685 0.97 (0.50 - 1.89) 0.928 
Female Ref - Ref - 
 
        
Age  1.04 (0.99 - 1.10) 0.1 0.99 (0.97 - 1.02) 0.661 
 
        
Education         
Primary 0.12 (0.26 - 0.60) 0.01* 1.32 (0.48 - 3.63) 0.585 
Secondary/Post-
Secondary 
0. 43 (0.12 - 1.54) 0.193 1.59 (0.61 - 4.12) 0.344 
Tertiary/Post-
Graduate 
Ref - Ref - 
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Discussion 
This study covered a representative 
sample of patients from the only oncology 
hospital in Malta, ensuring that patients with 
a range of disease characteristics and from 
different educational backgrounds were 
eligible for recruitment. Results can thus be 
regarded as reflective of the experience of 
Maltese oncology patients.  
Malta stands out in that, at present, 
there is no robust framework in place to help 
patients. In fact, the 2014 European Union 
Health Literacy (HL) Survey 16 (EU-HLS 
16) revealed that 42.5% of Maltese
considered themselves to have a
‘problematic’ level of HL, compared with
35.2% in the EU. Likewise, only 9.2% of
the Maltese sample graded themselves as
having ‘excellent’ HL, as opposed to 16.5%
in the EU.11 The EU-HLS 16 for Malta
echoes the main finding in our study – that
level of education plays a vital role in
choices patients make regarding their
treatment, with statistical significance for
the degree of HL at all education levels.
The CPS tool revealed that Maltese 
patients prefer a passive role in their 
treatment. This may change once legislation 
regarding patients’ rights is implemented. 
Creating a climate of increased awareness 
and availability of information may tip the 
balance towards Maltese patients becoming 
more emancipated in their health choices. 
The nation’s focus should change towards 
what can be done to improve health literacy. 
Since 7.6% of the Maltese population is 
illiterate,12 providing information to the 
population by audio and visual means will 
ensure equity for all.  
There were a number of limitations to 
this study. The MPP subscales were 
developed for an American population,4 
therefore extrapolating them to a Maltese 
population may not wholly reflect the 
cultural and treatment protocol differences 
within countries.  However, the tool was 
successfully applied in a number of 
countries including in Europe, reflecting 
flexibility of the tool.13-18  
Excluding some subjects from the study 
may have overlooked additional needs that 
these may have had, and possibly a different 
experience when compared to participants.  
Diagnosis was occasionally made 
several years prior to the study whereby 
respondents’ memories may have faded, 
introducing recall bias.  Furthermore, having 
re-experienced breaking bad news allowed 
some subjects increased ability to give 
feedback, which may also have introduced 
an element of bias, as subjects were not 
asked to specify which experience they were 
referring to. In retrospect, those with a 
recurrence could have been excluded, and 
more patients recruited so as not to lose the 
power of the study.   
Studies amongst Maltese cancer 
patients tend to be small due to our limited 
population size. This makes sub-group 
analysis difficult to power. To mitigate this, 
categorical dummy variables were created to 
ensure meaningful comparisons, while 
allowing for statistical power.  The study 
applied a cross-sectional design yet 
informational needs may change over time.19 
Future research may investigate how these 
may vary throughout the patient experience. 
Conclusion 
For Maltese patients, education level is 
a key factor influencing their preference for 
the type and amount of information they 
receive. Considering that the EU-HLS 16 
has shown a percentage of the Maltese 
population with a problematic level of HL, 
our MPP results are of relevance as they 
demonstrate that education plays a crucial 
role in treatment choices patients make. 
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Similarly, utilising the CPS revealed that 
Maltese patients overtly prefer a passive role 
in their treatment. As local legislation is 
implemented, this study can bolster support 
for initiatives to improve HL and increase 
awareness of patients’ rights, empowering 
patients to take an active or collaborative 
role in treatment decisions. This should lead 
to better patient satisfaction and hence 
improve supportive care to cancer patients. 
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